Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 27:17:2635-2646.
doi: 10.2147/JMDH.S432820. eCollection 2024.

On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients' Personal Experiences and Perspectives

Kasper Fjellhaugen Hjuler  1   2 , Louise Faurskov Møller  2   3 , Cathrine Dawn Büttner Elgaard  2   3 , Laura Gaïni  4 , Lars Iversen  2   3 , Tirill Fjellhaugen Hjuler  5
Affiliations

On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients' Personal Experiences and Perspectives

Kasper Fjellhaugen Hjuler et al. J Multidiscip Healthc. .

Abstract

Purpose: Immune-mediated inflammatory diseases (eg, axial spondylitis, psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and hidradenitis suppurativa) are common diseases that exert an extensive effect on the health-related quality of life, particularly when multiple concomitant conditions are present. Previous reports indicate that the traditional siloed approach to care can lead to a lack of patient centricity and inefficient disease management. In this article, we aimed to evaluate an interdisciplinary program for the treatment of immune-mediated inflammatory diseases compared to routine clinical practice.

Patients and methods: This was a mixed-method study, combining qualitative and quantitative data. Patients with co-occurrence of ≥2 immune-mediated inflammatory diseases treated in an interdisciplinary clinic (n = 48) or traditional usual care (n = 17) answered open-ended questions about their care experiences. Two independent coders blinded to patients' treatment group coded three aspects of the narratives provided by the patients' responses: Themes, Emotional valence, and Personal growth (ie, redemption). Themes were analyzed descriptively to explore possible differences between patients assigned to the interdisciplinary clinic and patients assigned to the usual care setting. Group differences in patients' emotional experiences were assessed, and we examined potential group differences in positive personal growth.

Results: Our findings indicate that an interdisciplinary combined clinic approach provides benefits for patients with multiple inflammatory diseases towards the usual setup. Patients experienced benefits on a number of specific quality-of-life themes including acceptance, optimism, disease understanding, personal growth, and better disease control. The narratives of the patients in the interdisciplinary group were significantly more emotionally positive and included more positive personal growth compared to the usual care group.

Conclusion: The findings indicate a patient-reported benefit, especially from the holistic approach and cross-specialty combined consultations in an interdisciplinary clinic compared to usual specialized healthcare, which was underscored by narratives highlighting an overall improved quality of life.

Keywords: axial spondylitis; hidradenitis suppurativa; inflammatory bowel disease; interdisciplinary care; patient-centered healthcare; psoriasis; psoriatic arthritis.

PubMed Disclaimer

Conflict of interest statement

The trial was not explicitly funded, but funding comes from general funding of The Danish National Center for Autoimmune Diseases by the Danish Ministry of Health. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Outside of the submitted word, Dr Kasper Fjellhaugen Hjuler has served as a consultant and advisor for the following companies: AbbVie, Bristol Myers Squibb (BMS), Janssen, LEO Pharma, UCB and Novartis, and has received speaking fees or grants from AbbVie, Eli Lilly, LEO Pharma, Novartis and Janssen. Outside of the submitted word, Miss Elgaard has received a personal scholarship from Novo Nordisk Foundation. Outside of the submitted work, Dr Iversen is employed by MC2 Therapeutics A/S and has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Astra Zeneca, BMS, Boehringer Ingelheim, Celgene, Centocor, Eli Lilly, Janssen Cilag, Kyowa, Leo Pharma, MSD, Novartis, Pfizer, Regranion, Samsung and Union Therapeutics UCB. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Emotional tone.
Figure 2
Figure 2
Redemption.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. El-Gabalawy H, Guenther LC, Bernstein CN. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol. 2010;85:2–10. doi:10.3899/jrheum.091461 - DOI - PubMed
    1. Russell AS, Gulliver WP, Irvine EJ, et al. Quality of life in patients with immune-mediated inflammatory diseases. J Rheumatol Suppl. 2011;88:7–19. doi:10.3899/jrheum.110899 - DOI - PubMed
    1. Skoie IM, Dalen I, Ternowitz T, et al. Fatigue in psoriasis: a controlled study. Br J Dermatol. 2017;177(2):505–512. doi:10.1111/bjd.15375 - DOI - PubMed
    1. Spierings J, Sloeserwij A, Vianen ME, et al. Health-related quality of life in patients with immune mediated inflammatory diseases: a cross-sectional, multidisciplinary study. Clin Immunol. 2020;214:108392. doi:10.1016/j.clim.2020.108392 - DOI - PubMed
    1. Daugaard C, Iversen L, Hjuler KF. Comorbidity in Adult Psoriasis: considerations for the Clinician. Psoriasis. 2022;12:139–150. doi:10.2147/PTT.S328572 - DOI - PMC - PubMed